We are live on ! Find out more
PFO

Pathstone Family Office Portfolio holdings

AUM $13.1B
1-Year Est. Return 21.02%
This Fund
S&P 500
This Quarter Est. Return
+8.39%
1 Year Est. Return
+21.02%
3 Year Est. Return
+39.27%
5 Year Est. Return
+59.55%
10 Year Est. Return
+237.03%
AUM
$11.7B
AUM Growth
+$657M
Cap. Flow
+$823M
Cap. Flow %
7.02%
Top 10 Hldgs %
29.51%
Holding
1,637
New
161
Increased
846
Reduced
407
Closed
144

Sector Composition

Rank Sector Weight
1 Technology 12.36%
2 Healthcare 8.23%
3 Financials 6.88%
4 Consumer Discretionary 6.01%
5 Consumer Staples 5.44%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
DXC icon
401
DXC Technology
DXC
$1.73B
$2.89M 0.02%
110,990
-29,904
-21% -$832K
EL icon
402
Estee Lauder
EL
$32B
$2.88M 0.02%
15,008
+4,741
+46% +$1.06M
BF.A icon
403
Brown-Forman Class A
BF.A
$13.3B
$2.88M 0.02%
15,178
+91
+0.6% +$6.21K
TFLO icon
404
iShares Treasury Floating Rate Bond ETF
TFLO
$6.64B
$2.87M 0.02%
+57,008
New +$2.88M
JKHY icon
405
Jack Henry & Associates
JKHY
$11.1B
$2.87M 0.02%
19,794
+3,679
+23% +$679K
ETSY icon
406
Etsy
ETSY
$7.85B
$2.86M 0.02%
22,568
+9,426
+72% +$1.08M
WY icon
407
Weyerhaeuser
WY
$18.4B
$2.85M 0.02%
106,782
+18,731
+21% +$580K
GIS icon
408
General Mills
GIS
$19.7B
$2.84M 0.02%
51,760
+9,656
+23% +$786K
JBGS
409
JBG SMITH
JBGS
$708M
$2.83M 0.02%
147,396
+19,090
+15% +$369K
GSK icon
410
GSK
GSK
$106B
$2.79M 0.02%
43,978
-7,473
-15% -$249K
SLB icon
411
SLB Ltd
SLB
$75B
$2.77M 0.02%
71,380
+30,388
+74% +$1.51M
JBL icon
412
Jabil
JBL
$35.8B
$2.76M 0.02%
43,616
+1,250
+3% +$82.6K
LKQ icon
413
LKQ Corp
LKQ
$6.29B
$2.75M 0.02%
51,684
+6,974
+16% +$369K
MRO
414
DELISTED
Marathon Oil Corporation
MRO
$2.75M 0.02%
166,644
+75,261
+82% +$2.18M
AVDE icon
415
Avantis International Equity ETF
AVDE
$18.7B
$2.74M 0.02%
51,580
-43,484
-46% -$2.21M
DHI icon
416
D.R. Horton
DHI
$42.3B
$2.73M 0.02%
35,256
+14,449
+69% +$1.16M
MRNA icon
417
Moderna
MRNA
$23.6B
$2.72M 0.02%
19,662
+7,317
+59% +$1.2M
CRWD icon
418
CrowdStrike
CRWD
$218B
$2.71M 0.02%
56,280
+3,516
+7% +$120K
PAYX icon
419
Paychex
PAYX
$42.7B
$2.69M 0.02%
31,420
+10,339
+49% +$1.21M
ALB icon
420
Albemarle
ALB
$15.5B
$2.68M 0.02%
11,682
+822
+8% +$219K
DECK icon
421
Deckers Outdoor
DECK
$13.3B
$2.67M 0.02%
48,792
-7,284
-13% -$441K
EWA icon
422
iShares MSCI Australia ETF
EWA
$1.45B
$2.63M 0.02%
118,414
-4,726
-4% -$103K
SBAC icon
423
SBA Communications
SBAC
$19.5B
$2.63M 0.02%
10,630
+3,117
+41% +$868K
HLT icon
424
Hilton Worldwide
HLT
$71.5B
$2.62M 0.02%
28,070
+4,876
+21% +$643K
DUK icon
425
Duke Energy
DUK
$97.3B
$2.6M 0.02%
38,652
+11,620
+43% +$1.12M

Similar funds

Pathstone Family Office's Q4 2022 Portfolio in Review

As of Q4 2022, Pathstone Family Office held 1,637 positions worth $11.7B, up 5.9% from $11.1B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Pathstone Family Office deployed $823M of net new capital in Q4 2022, opening 161 new positions and adding to 846 existing holdings. Its largest new stake was Dimensional US Large Cap Value ETF: 7,009,786 shares worth $172M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Vanguard Morningstar Value ETF, an estimated $173M trimmed.

  • Pathstone Family Office's largest Q4 2022 buy was Dimensional US Large Cap Value ETF: 7,009,786 shares worth $172M.
  • Pathstone Family Office added most to iShares Short-Term National Muni Bond ETF in Q4 2022, an estimated $70.2M increase.
  • Pathstone Family Office's biggest Q4 2022 reduction was Vanguard Morningstar Value ETF, cutting an estimated $173M.
  • Pathstone Family Office fully exited Invesco Senior Loan ETF in Q4 2022, selling an estimated $82.4M.
  • Pathstone Family Office's ten largest holdings make up 30% of its $11.7B portfolio in Q4 2022.
  • Pathstone Family Office opened 161 new positions and closed 144 in Q4 2022.
  • Pathstone Family Office's portfolio value rose 5.9% quarter-over-quarter to $11.7B.

Based on Pathstone Family Office's 13F filing for Q4 2022, filed 13 Feb 2023.